Literature DB >> 28672950

Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β.

Chuanhui Xun1, Mardan Mamat1, Hailong Guo1, Pulat Mamati1, Jun Sheng1, Jian Zhang1, Tao Xu1, Weidong Liang1, Rui Cao1, Weibin Sheng1.   

Abstract

In recent years accumulating evidence has indicated that tocotrienol exhibits an oxidation resistance function, decreased cholesterol function, inhibits cancer function and has unique physiological functions, including anti-inflammatory, anti-apoptotic and anti-oxidative properties. The present study investigated the effect of tocotrienols on spinal cord injury (SCI) by evaluating oxidative stress, inflammation and inducible nitric oxide synthase (iNOS) in rats. A rat model of SCI was induced by operation. SCI rats were treated with 120 mg/kg/day tocotrienol once a day for eight consecutive weeks. Functional recovery following SCI was measured by using the Basso Beattie Bresnahan (BBB) locomotor rating scale. Then the volume of spinal cord contusions was measured following induction of SCI in the rats. In SCI rats, serum malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, nuclear factor-κB p65 unit, tumor necrosis factor-α, interleukin (IL)-1β and IL-6 levels were analyzed using respective commercial immunoassay kits. Firstly, iNOS, transforming growth factor (TGF)-β, collagen type IV and fibronectin protein expression levels, in addition to iNOS activity and plasma nitric oxide (NO) production in SCI rats was analyzed using western blot analysis, commercial kits and Griess reagent, respectively. Tocotrienol treatment elevated BBB scores and contused volume in the SCI rats. Tocotrienol protected against SCI with reduced oxidative stress and inflammation, and inhibited iNOS protein expression iNOS activity and plasma NO production in rats. In addition, treatment with tocotrienols suppressed TGF-β, collagen type IV and fibronectin protein expression levels in SCI rats. These results suggest that tocotrienols protect SCI, and suppress oxidative stress, inflammation and iNOS in this model of SCI through TGF-β, collagen type IV and fibronectin signaling pathways.

Entities:  

Keywords:  inducible nitric oxide synthase; inflammation; oxidative stress; spinal cord injury; tocotrienol

Year:  2017        PMID: 28672950      PMCID: PMC5488605          DOI: 10.3892/etm.2017.4505

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  40 in total

1.  Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3.

Authors:  Alice Banh; Paula A Deschamps; Jack Gauldie; Paul A Overbeek; Jacob G Sivak; Judith A West-Mays
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

Review 2.  Potential role of tocotrienols in the treatment and prevention of breast cancer.

Authors:  Paul W Sylvester; Mohamed R Akl; Abhita Malaviya; Parash Parajuli; Suryatheja Ananthula; Roshan V Tiwari; Nehad M Ayoub
Journal:  Biofactors       Date:  2013-06-27       Impact factor: 6.113

Review 3.  Do tocotrienols have potential as neuroprotective dietary factors?

Authors:  Jan Frank; Xiao Wei Dawn Chin; Charlotte Schrader; Gunter P Eckert; Gerald Rimbach
Journal:  Ageing Res Rev       Date:  2011-07-07       Impact factor: 10.895

4.  Therapeutic effect of transplanting bone mesenchymal stem cells on the hind limbs' motor function of rats with acute spinal cord injury.

Authors:  Qinghua Song; Rongmei Xu; Quanhai Zhang; Ming Ma; Xinping Zhao
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  Distribution of tocopherols and tocotrienols to rat ocular tissues after topical ophthalmic administration.

Authors:  Masaki Tanito; Nanako Itoh; Yasukazu Yoshida; Mieko Hayakawa; Akihiro Ohira; Etsuo Niki
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

6.  Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar.

Authors:  Päivi Liesi; Timo Kauppila
Journal:  Exp Neurol       Date:  2002-01       Impact factor: 5.330

7.  The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat.

Authors:  Xianghua Wang; Weiping Chen; Wangmi Liu; Jiayan Wu; Yanqi Shao; Xiaoming Zhang
Journal:  J Clin Neurosci       Date:  2009-04-01       Impact factor: 1.961

Review 8.  Utilizing Fibronectin Integrin-Binding Specificity to Control Cellular Responses.

Authors:  Haylee Bachman; John Nicosia; Marilyn Dysart; Thomas H Barker
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

9.  Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity.

Authors:  R Loganathan; K R Selvaduray; K Nesaretnam; A K Radhakrishnan
Journal:  Cell Prolif       Date:  2013-04       Impact factor: 6.831

10.  TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons.

Authors:  Mahesh Kandasamy; Bernadette Lehner; Sabrina Kraus; Paul Ramm Sander; Julia Marschallinger; Francisco J Rivera; Dietrich Trümbach; Uwe Ueberham; Herbert A Reitsamer; Olaf Strauss; Ulrich Bogdahn; Sebastien Couillard-Despres; Ludwig Aigner
Journal:  J Cell Mol Med       Date:  2014-04-30       Impact factor: 5.310

View more
  5 in total

1.  [Icariin alleviates lipid peroxidation after spinal cord injury in rats].

Authors:  Xian-Sheng Ren; Wei Ding; Xiao-Yu Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

Review 2.  Anti-inflammatory Activity of Tocotrienols in Age-related Pathologies: A SASPected Involvement of Cellular Senescence.

Authors:  Marco Malavolta; Elisa Pierpaoli; Robertina Giacconi; Andrea Basso; Maurizio Cardelli; Francesco Piacenza; Mauro Provinciali
Journal:  Biol Proced Online       Date:  2018-11-20       Impact factor: 3.244

Review 3.  Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy.

Authors:  Geetha Maniam; Chun-Wai Mai; Mohd Zulkefeli; Christine Dufès; Doryn Meam-Yee Tan; Ju-Yen Fu
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

4.  Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model.

Authors:  Jun Noichi; Tomoko Ishiakawa; Ikuyo Ichi; Yoko Fujiwara
Journal:  J Clin Biochem Nutr       Date:  2021-10-02       Impact factor: 3.114

Review 5.  Inflammation: A Target for Treatment in Spinal Cord Injury.

Authors:  Ximena Freyermuth-Trujillo; Julia J Segura-Uribe; Hermelinda Salgado-Ceballos; Carlos E Orozco-Barrios; Angélica Coyoy-Salgado
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.